Skip to main content
OpenTrials

Clinical trial condition

Sickle Cell Disease (SCD)

Explore clinical trials studying Sickle Cell Disease (SCD). Study availability and eligibility vary by location and protocol.

21 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Sickle Cell Disease (SCD) trial results

Completed

Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients

NCT03474965

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +19 more
Locations
  • University Of Alabama Birmingham, Alabama, United States
  • Childrens National Hospital Washington D.C., District of Columbia, United States
  • University of Florida Gainesville, Florida, United States
  • Joe DiMaggio Childrens Hospital Hollywood, Florida, United States
View all 35 locations
View Trial Details
Completed

An Indian Multi-centric Phase IV Study to Assess the Safety of Crizanlizumab in Sickle Cell Disease Patients

NCT04662931

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +9 more
Locations
  • Novartis Investigative Site Guwahati, Assam, India
  • Novartis Investigative Site Raipur, Chhattisgarh, India
  • Novartis Investigative Site Kozhikode, Kerala, India
  • Novartis Investigative Site Bhubaneswar, Odisha, India
View Trial Details
Completed

Pharmacokinetics and Pharmacodynamics Study of SEG101 (Crizanlizumab) in Sickle Cell Disease (SCD) Patients With Vaso- Occlusive Crisis (VOC)

NCT03264989

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +9 more
Locations
  • Novartis Investigative Site Orange, Florida, United States
  • Novartis Investigative Site Tampa, Florida, United States
  • Childrens Healthcare of Atlanta . Atlanta, Georgia, United States
  • Augusta University Georgia Patient Treatment Augusta, Georgia, United States
View Trial Details
Completed

Study Exploring the Effect of Crizanlizumab on Kidney Function in Patients With Chronic Kidney Disease Caused by Sickle Cell Disease

NCT04053764

Conditions
Albuminuria, Anemia, Anemia, Hemolytic, +24 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • University of Illinois Hospital and Health Sciences System . Chicago, Illinois, United States
  • Our Lady of the Lake Regional Medic . Baton Rouge, Louisiana, United States
  • East Carolina University BrodySchool of Med 3 Greenville, North Carolina, United States
View all 24 locations
View Trial Details

Related conditions